Methylphenidate

This classification denotes a cns stimulant with the molecular formula C14H19NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 207ZZ9QZ49, chemically known as 2-piperidineacetic acid, .alpha.-phenyl-, methyl ester, hydrochloride but more generally known as methylphenidate, which bears US NIH Compound Identifier 4158. European Medicines Agency schedules Methylphenidate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08870MIG. The term METHYLPHENIDATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules methylphenidate in its Anatomical Therapeutic Chemical (ATC) Classification. METHYLPHENIDATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule methylphenidate under HS 29333300 and SITC 51574. As of Q4 2014, METHYLPHENIDATE remains US FDA's Preferred Term for this commodity. Methylphenidate bears US NLM identifiers UMLS ID C0025810 and NCI Concept Code C62045. SMILES: O(C(=O)C(C1NCCCC1)C1CCCCC1)C.